Novo provides update on the denecimig Biologics LicenseApplication (BLA) in the US
The following is a news release from Novo. Read the full release at novonordisk.com Bagsværd, Denmark, 02 October 2026 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has informed Novo that the BLA review of denecimig for the treatment of haemophilia A, with or without inhibitors in adults and children, […]
Word From Washington: An Update on Federal Bleeding Disorders Programs
By Adam Alver, Policy Director Following HFA’s Symposium, Word From Washington Returns HFA is providing a spring update on the status of bleeding disorders programs under the federal government, including funding of the nation’s more than 140 Hemophilia Treatment Centers and the activities at the CDC’s Division of Blood Disorders and Public Health Genomics. We want to express our […]
2026 Annual Award Winners
HFA announced its annual award winners at Symposium in New Orleans. This year’s awards and winners include: Charles Stanley Hamilton Legacy Award This award is for extraordinary lifetime service that encompasses national volunteerism, professionalism and leadership. Charles was a Louisiana native who suffered from severe hemophilia A and who passed far too soon. He was the son […]
English 
Español de Puerto Rico